(1)
Cantrell, W.; Lee, P.; Mendelsohn, A. M.; Parno, J.; Rozzo, S. J.; Liao, W. Efficacy and Safety of Tildrakizumab 100 Mg for Plaque Psoriasis in Patients Randomized to Treatment Continuation Vs Treatment Withdrawal With Retreatment Upon Relapse in Resurface 1. J of Skin 2020, 4, s40.